Ending an Epidemic – In spite of an impact on an estimated 185 million people globally that includes close to half a million deaths yearly, attention to hepatitis C has lagged in the years since the virus was identified, but the recent development of new drugs has brought both recognition of what can be done […]
HIV
The science is clear, HIV criminalization is abusive, discriminatory and counterproductive – The destructiveness of HIV-specific laws that fueled stigma and discouraged diagnosis by criminalizing people […]
Tuberculosis
THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
So many lessons are offered in a recent communication from the U.S. Centers for Disease Control and Prevention about antibiotic-resistant infections among patients returning to the […]